Phase 2 (~50% of patients evaluated to date at 12 months) shows 46% lesion growth reduction vs. controlThere are no ...

Ocugen, Inc. gene therapy outlook: key 2026 catalysts, Phase 2/3 eye-disease data, BLA plans to 2028, and risks. Click for ...

Ocugen has reported preliminary phase 2 data on its eye disease gene therapy, providing more evidence that the candidate may ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Ocugen OCGN is making rapid progress in its gene therapy programs for retinal diseases, which have differentiated mechanisms of action. With all three key pipeline programs moving on schedule, Ocugen ...

Ocugen has announced positive preliminary 12-month data from its phase 2 ArMaDa trial evaluating OCU410 (AAV5-RORA) for the ...

Whether you’re in the mood for live music, theater or a night of laughs, metro Atlanta has no shortage of ways to spend your weekend. Police say a man was shot during a domestic-related incident ...

16-year-old Lequan Stephens was turned in by his father at the Clayton County Police Department Tuesday after being accused in two separate shootings. Two Atlanta armed robbery suspects were arrested ...

MACON, Ga. — A warmer night ahead compared to last night, but still cold. Cloud cover is back in the picture with a return of showers tomorrow throughout the day. A quick warm-up will occur as we're ...

Yakuza Kiwami 3 and Dark Ties brings a host of gameplay tweaks and new additions to address the criticisms of the original ...

Prefoldin 5 stabilises neuronal microtubules and suppresses Tau-mediated neurotoxicity, offering a potential therapeutic target for tauopathies.